Replay available

Nephros, Inc. (NEPH) Q4 2025 Earnings Call

Nephros, Inc. (NASDAQ: NEPH) Q4 2025 earnings conference call, held 2026-03-12. Replay captured from the company's public earnings webcast.

Thu, March 12, 2026 at 4:30 PMendedReplay
Nephros, Inc. (NEPH) Q4 2025 Earnings Call

Hosted by

Featured presenters

Judy Crandall

Chief Financial Officer

Ralph Wheel

Analyst, R. Wheel Investment Management

Kieran Smith

Investor Relations, TCG Advisory

Anthony Vendetti

Analyst, Maxim Group

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nephros, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.419 Good afternoon, everyone, and welcome to the Nefrosync 4th Quarter 2025 Financial Results 00:00:05.419 -- 00:00:07.419 Conference. 00:00:07.542 -- 00:00:10.266 All participants will be in a listen-only mode. 00:00:10.266 -- 00:00:14.172 Should you need assistance, please signal a conference specialist by pressing the star 00:00:14.172 -- 00:00:16.956 key followed by zero. 00:00:16.956 -- 00:00:20.682 After today's presentation, there will be an opportunity to ask questions. 00:00:20.682 -- 00:00:24.988 To ask a question, you may press star and then one on your touch-tone telephones. 00:00:24.988 -- 00:00:28.330 To withdraw your questions, you may press star and two. 00:00:28.330 -- 00:00:32.012 Please also note today's event is being recorded. 00:00:32.215 -- 00:00:37.162 At this time, I would like to turn the floor over to Kieran Smith, Investor Relations. 00:00:37.162 -- 00:00:39.563 Please go ahead. 00:00:39.926 -- 00:00:41.909 Thank you, Jamie, and good afternoon, everyone. 00:00:41.909 -- 00:00:47.176 This is Kieran Smith with TCG Advisory. Thank you all for participating in NEPHRO's 00:00:47.176 -- 00:00:51.062 fourth quarter and fiscal year 2025 conference call. 00:00:51.062 -- 00:00:55.027 Before we begin, I would like to caution that comments made during this conference call 00:00:55.027 -- 00:00:59.400 by management will contain forward-looking statements regarding the operations and future 00:00:59.400 -- 00:01:04.006 results of NEPHROs. I encourage you to review NEPHROs' filings with the Securities and 00:01:04.006 -- 00:01:09.433 Exchange Commission, including without limitation the company's forms 10-K and 10-Q, 00:01:09.433 -- 00:01:14.559 which identify specific factors that make those actual results or events diffe...